Studying Inflammation and Heart Disease Risk in Adults with Myelodysplastic Syndromes

What this Trial Is About

Researchers are investigating why people with myelodysplastic syndromes MDS, a type of blood cancer, have a higher risk of heart problems such as heart disease and stroke. The study aims to understand if certain inflammation-related proteins in the blood can help predict these cardiovascular issues in patients with MDS. By gaining better insight, the research hopes to improve ways to detect and manage heart disease risks in these patients. This observational study will follow adults with MDS over a period of 6 months. Participants will attend an initial hospital visit to learn about the study, provide consent, share health information, and give a fasting blood sample. Following this, participants will return weekly for 3 weeks to provide more fasting blood samples. Then, they will have monthly visits for the next 5 months to discuss health changes and provide additional blood samples. All blood collections will occur during routine clinical care visits and take about 20 minutes each. During the study, researchers will collect small amounts of blood at each visit to measure markers of inflammation. Participants will receive reminder calls before blood draws. No treatments are given as part of this study instead, the focus is on monitoring blood markers and health changes. The main outcome is to observe the natural variability of inflammation markers over 6 months. Participation helps researchers learn about inflammations role in heart health for people with MDS.

Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes